Proto Script Pharmaceutical (Proto Script Pharmaceutical) Capex-to-Operating-Cash-Flow : 0.00 (As of Sep. 2017)

Proto Script Pharmaceutical Capex-to-Operating-Cash-Flow Chart

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
Capex-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow falls into.

Proto Script Pharmaceutical Capex-to-Operating-Cash-Flow Calculation

Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow for the fiscal year that ended in May. 2016 is calculated as

Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow for the quarter that ended in Sep. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical  (OTCPK:PSCR) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.

Proto Script Pharmaceutical Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description